drugset / Trial / NCT00860340
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
NaSingle-groupOpen-labelTreatment
Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
Timeline
- Start
- 2003-02
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | 100 mg | Oral |